Trial intelligence / Profile preview

Effectiveness of Potassium Supplement in Hypokalemic PD Patients

TCTR20190725004Completed

Sponsor
Faculty of Medicine, Chulalongkorn University
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of potassium chloride in hypokalemia and end-stage kidney disease (ESKD) (2 arms), sponsored by Faculty of Medicine, Chulalongkorn University. Started Jan 2020; status: completed.

02

Drugs

potassium chloride
03

Conditions

hypokalemiaend-stage kidney disease (ESKD)

Beyond the preview

Go deeper on TCTR20190725004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190725004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call